About this episode
Pharmac is now funding a new medicine and has removed renewal criteria for ADHD treatments.
Advocates are welcoming the move – saying it’s a game-changer that will save the health system tens of millions of dollars.
But, there are warnings it could lead to over-diagnosing and over-prescribing.
Today on The Front Page, co-founder of DivergenThinking and registered psychologist, Anton Ashcroft joins us to discuss.
Follow The Front Page on iHeartRadio, Apple Podcasts, Spotify or wherever you get your podcasts.
You can read more about this and other stories in the New Zealand Herald, online at nzherald.co.nz, or tune in to news bulletins across the NZME network.
Host: Chelsea Daniels
Sound Engineer/Producer: Richard Martin
Producer: Ethan Sills
See omnystudio.com/listener for privacy information.
Get every episode summarized
Each time The Front Page publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Front Page
Are we buying the wrong cars in the fuel crisis EV boom?
The Front Page
How illicit tobacco quietly grew to a quarter of all cigarettes sold here
The Front Page
Why Trump’s Iran blockade could backfire at sea
The Front Page
Inside the push to fix Luxon’s media image
The Front Page